Distribution, size, shape, growth potential and extent of abdominal aortic calcified deposits predict mortality in postmenopausal women
- PMID: 21067610
- PMCID: PMC2996339
- DOI: 10.1186/1471-2261-10-56
Distribution, size, shape, growth potential and extent of abdominal aortic calcified deposits predict mortality in postmenopausal women
Abstract
Background: Aortic calcification is a major risk factor for death from cardiovascular disease. We investigated the relationship between mortality and the composite markers of number, size, morphology and distribution of calcified plaques in the lumbar aorta.
Methods: 308 postmenopausal women aged 48-76 were followed for 8.3 ± 0.3 years, with deaths related to cardiovascular disease, cancer, or other causes being recorded. From lumbar X-rays at baseline the number (NCD), size, morphology and distribution of aortic calcification lesions were scored and combined into one Morphological Atherosclerotic Calcification Distribution (MACD) index. The hazard ratio for mortality was calculated for the MACD and for three other commonly used predictors: the EU SCORE card, the Framingham Coronary Heart Disease Risk Score (Framingham score), and the gold standard Aortic Calcification Severity score (AC24) developed from the Framingham Heart Study cohorts.
Results: All four scoring systems showed increasing age, smoking, and raised triglyceride levels were the main predictors of mortality after adjustment for all other metabolic and physical parameters. The SCORE card and the Framingham score resulted in a mortality hazard ratio increase per standard deviation (HR/SD) of 1.8 (1.51-2.13) and 2.6 (1.87-3.71), respectively. Of the morphological x-ray based measures, NCD revealed a HR/SD >2 adjusted for SCORE/Framingham. The MACD index scoring the distribution, size, morphology and number of lesions revealed the best predictive power for identification of patients at risk of mortality, with a hazard ratio of 15.6 (p < 0.001) for the 10% at greatest risk of death.
Conclusions: This study shows that it is not just the extent of aortic calcification that predicts risk of mortality, but also the distribution, shape and size of calcified lesions. The MACD index may provide a more sensitive predictor of mortality from aortic calcification than the commonly used AC24 and SCORE/Framingham point card systems.
Figures




Similar articles
-
Abdominal aortic calcification quantified by the Morphological Atherosclerotic Calcification Distribution (MACD) index is associated with features of the metabolic syndrome.BMC Cardiovasc Disord. 2011 Dec 20;11:75. doi: 10.1186/1471-2261-11-75. BMC Cardiovasc Disord. 2011. PMID: 22185588 Free PMC article.
-
Association of abdominal aortic calcification estimated by plain radiography with outcomes in haemodialysis patients: A 6-year follow-up study.Nephrology (Carlton). 2020 Jul;25(7):559-565. doi: 10.1111/nep.13644. Epub 2019 Aug 30. Nephrology (Carlton). 2020. PMID: 31424612
-
Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study.J Am Soc Nephrol. 2003 Jan;14(1):159-68. doi: 10.1097/01.asn.0000038685.95946.83. J Am Soc Nephrol. 2003. PMID: 12506148
-
Prediction of mortality using a multi-bed vascular calcification score in the Diabetes Heart Study.Cardiovasc Diabetol. 2014 Dec 12;13:160. doi: 10.1186/s12933-014-0160-5. Cardiovasc Diabetol. 2014. PMID: 25496604 Free PMC article.
-
Aortic calcification.Eur J Vasc Endovasc Surg. 2005 Nov;30(5):476-88. doi: 10.1016/j.ejvs.2005.04.030. Epub 2005 Jun 15. Eur J Vasc Endovasc Surg. 2005. PMID: 15963738 Review.
Cited by
-
Prognostic Value of Abdominal Aortic Calcification: A Systematic Review and Meta-Analysis of Observational Studies.J Am Heart Assoc. 2021 Jan 19;10(2):e017205. doi: 10.1161/JAHA.120.017205. Epub 2021 Jan 13. J Am Heart Assoc. 2021. PMID: 33439672 Free PMC article.
-
Abdominal aortic calcification quantified by the Morphological Atherosclerotic Calcification Distribution (MACD) index is associated with features of the metabolic syndrome.BMC Cardiovasc Disord. 2011 Dec 20;11:75. doi: 10.1186/1471-2261-11-75. BMC Cardiovasc Disord. 2011. PMID: 22185588 Free PMC article.
References
-
- Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, Grady D, Haan CK, Hayes SN, Judelson DR, Keenan NL, McBride P, Oparil S, Ouyang P, Oz MC, Mendelsohn ME, Pasternak RC, Pinn VW, Robertson RM, Schenck-Gustafsson K, Sila CA, Smith SC Jr, Sopko G, Taylor AL, Walsh BW, Wenger NK, Williams CL. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2004;109:672–693. doi: 10.1161/01.CIR.0000114834.85476.81. - DOI - PubMed
-
- Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, Grady D, Haan CK, Hayes SN, Judelson DR, Keenan NL, McBride P, Oparil S, Ouyang P, Oz MC, Mendelsohn ME, Pasternak RC, Pinn VW, Robertson RM, Schenck-Gustafsson K, Sila CA, Smith SC Jr, Sopko G, Taylor AL, Walsh BW, Wenger NK, Williams CL. Evidence-based guidelines for cardiovascular disease prevention in women. J Am Coll Cardiol. 2004;43:900–921. doi: 10.1016/j.jacc.2004.02.001. - DOI - PubMed
-
- Karsdal MA, Henriksen K, Leeming DJ, Mitchell P, Duffin K, Barascuk N, Klickstein L, Aggarwal P, Nemirovskiy O, Byrjalsen I, Qvist P, Bay-Jensen AC, Dam EB, Madsen SH, Christiansen C. Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development. Biomarkers. 2009;14:181–202. doi: 10.1080/13547500902777608. - DOI - PubMed
-
- De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Cats VM, Orth-Gomer K, Perk J, Pyorala K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts) Atherosclerosis. 2004;173:381–391. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources